Global Mandibular Advancement Device Market Size By Type (Metal, Plastic), By Application (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Mandibular Advancement Device Market was valued at USD 1.2 billion in 2023 and is projected to surpass USD 2.1 billion by 2031, growing at a CAGR of 7.2% during the forecast period from 2023 to 2031. Mandibular advancement devices (MADs) are increasingly used in the treatment of obstructive sleep apnea (OSA) and snoring, offering a non-invasive alternative to CPAP therapy. The growth of this market is primarily fueled by rising awareness of sleep disorders, an aging population, and technological advancements in dental sleep medicine.

Drivers

Rising Prevalence of Obstructive Sleep Apnea (OSA):

An increasing number of people worldwide are being diagnosed with OSA due to sedentary lifestyles, obesity, and aging. MADs are a widely accepted treatment for mild to moderate OSA, which is driving their global demand.

Non-Invasive Alternative to CPAP Therapy:

Many patients find CPAP devices uncomfortable and non-compliant. MADs offer a convenient, patient-friendly, and effective alternative for OSA treatment, contributing to higher adoption rates.

Technological Advancements in Custom-Fit Devices:

Recent innovations in 3D printing, digital impressions, and customization technologies have led to more comfortable and effective devices, enhancing patient compliance and driving market growth.

Restraints

Limited Efficacy for Severe OSA Cases:

MADs are less effective for patients with severe OSA, limiting their scope and making CPAP or surgical interventions necessary in such cases.

Reimbursement Challenges and High Costs:

In several regions, insurance reimbursement for MADs is limited or inconsistent, which can be a barrier to widespread adoption, particularly in developing economies.

Opportunity

Rising Awareness and Screening Initiatives:

Global campaigns to raise awareness of sleep apnea, coupled with increasing efforts by healthcare providers to screen patients, present growth opportunities for MAD adoption.

Untapped Emerging Markets:

Emerging economies in Asia-Pacific and Latin America are witnessing rapid healthcare infrastructure development, increasing awareness of sleep disorders, and rising disposable incomes—factors that are expected to boost demand for MADs.

Market by System Type Insights

Based on system type, the Custom-Fit Mandibular Advancement Devices segment dominated the market in 2023. These devices offer superior fit, comfort, and effectiveness compared to boil-and-bite or prefabricated alternatives. The custom-fit segment is projected to maintain its lead throughout the forecast period, driven by increasing clinical endorsements and technological innovations in dental labs.

Market by End-use Insights

The Sleep Clinics segment emerged as the largest revenue contributor in 2023, accounting for over 45% of the market share. Sleep clinics play a critical role in diagnosing and treating OSA, and the collaboration between dentists and sleep physicians has significantly increased MAD prescriptions. The Home Care Settings segment is also expected to witness rapid growth due to the rise in at-home sleep monitoring and therapy trends.

Market by Regional Insights

North America led the market in 2023, owing to high awareness, well-established dental and sleep medicine infrastructure, and strong reimbursement frameworks. Meanwhile, Asia-Pacific is projected to witness the highest CAGR during the forecast period. Increasing healthcare expenditure, large undiagnosed OSA populations, and growing urbanization are fueling growth in countries like China, India, and Japan.

Competitive Scenario

Key players in the Global Mandibular Advancement Device Market include ResMed Inc., SomnoMed Ltd., Whole You Inc., Apnea Sciences Corporation, ProSomnus Sleep Technologies, Panthera Dental, Airway Management Inc., and GlaxoSmithKline plc. These companies are focusing on clinical efficacy studies, product innovation, and strategic partnerships to strengthen market presence.

Recent Developments:

In 2023, ProSomnus received FDA 510(k) clearance for its next-generation precision MAD for OSA treatment.

In 2024, ResMed partnered with dental sleep networks in Europe to expand the adoption of digitally customized MADs.

In 2025, SomnoMed announced a new AI-driven platform to optimize treatment outcomes based on patient-specific feedback.

Scope of Work – Global Mandibular Advancement Device Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.1 billion

CAGR (2023–2031) 7.2%

Market Segments By System Type (Custom-Fit, Prefabricated), By End-Use (Sleep Clinics, Home Care Settings), By Region

Growth Drivers Rising prevalence of sleep apnea, non-invasive nature of treatment, technological advancements

Opportunities Expansion in emerging markets, increasing awareness & screening initiatives

Key Market Developments

2023: ProSomnus secured FDA clearance for a high-precision, 3D-printed MAD designed for better patient compliance.

2024: SomnoMed expanded into Southeast Asia through local distribution partnerships and education campaigns.

2025: Airway Management Inc. launched a new adjustable MAD that allows patients to self-calibrate treatment at home.

FAQs

What is the current market size of the Global Mandibular Advancement Device Market?

The market size was valued at USD 1.2 billion in 2023.

What is the major growth driver of the Global Mandibular Advancement Device Market?

The major driver is the rising prevalence of sleep apnea and increasing demand for non-invasive treatment alternatives.

Which is the largest region during the forecast period in the Global Mandibular Advancement Device Market?

North America is the largest region, driven by high diagnosis rates and advanced healthcare infrastructure.

Which segment accounted for the largest market share in the Global Mandibular Advancement Device Market?

The Custom-Fit Devices segment accounted for the largest market share in 2023.

Who are the key market players in the Global Mandibular Advancement Device Market?

Key players include ResMed Inc., SomnoMed Ltd., Whole You Inc., ProSomnus Sleep Technologies, and Panthera Dental.